{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:40:33Z","timestamp":1790833233316,"version":"4.1.0"},"reference-count":122,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T00:00:00Z","timestamp":1652572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Ministry of Science and Higher Education of the Russian Federation","award":["075-15-2019-1661"],"award-info":[{"award-number":["075-15-2019-1661"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Adeno-associated virus (AAV) vectors have become an attractive tool for efficient gene transfer into animal tissues. Extensively studied as the vehicles for therapeutic constructs in gene therapy, AAVs are also applied for creating animal models of human genetic disorders. Neurological disorders are challenging to model in laboratory animals by transgenesis or genome editing, at least partially due to the embryonic lethality and the timing of the disease onset. Therefore, gene transfer with AAV vectors provides a more flexible option for simulating genetic neurological disorders. Indeed, the design of the AAV expression construct allows the reproduction of various disease-causing mutations, and also drives neuron-specific expression. The natural and newly created AAV serotypes combined with various delivery routes enable differentially targeting neuronal cell types and brain areas in vivo. Moreover, the same viral vector can be used to reproduce the main features of the disorder in mice, rats, and large laboratory animals such as non-human primates. The current review demonstrates the general principles for the development and use of AAVs in modeling neurological diseases. The latest achievements in AAV-mediated modeling of the common (e.g., Alzheimer\u2019s disease, Parkinson\u2019s disease, ataxias, etc.) and ultra-rare disorders affecting the central nervous system are described. The use of AAVs to create multiple animal models of neurological disorders opens opportunities for studying their mechanisms, understanding the main pathological features, and testing therapeutic approaches.<\/jats:p>","DOI":"10.3390\/biomedicines10051140","type":"journal-article","created":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T09:48:22Z","timestamp":1652608102000},"page":"1140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1361-6117","authenticated-orcid":false,"given":"Evgenii","family":"Lunev","sequence":"first","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"},{"name":"Marlin Biotech LLC, 354340 Sochi, Russia"},{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Karan","sequence":"additional","affiliation":[{"name":"Marlin Biotech LLC, 354340 Sochi, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3346-3242","authenticated-orcid":false,"given":"Tatiana","family":"Egorova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"},{"name":"Marlin Biotech LLC, 354340 Sochi, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryana","family":"Bardina","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"},{"name":"Marlin Biotech LLC, 354340 Sochi, Russia"},{"name":"Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, 119334 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,5,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","article-title":"Global, Regional, and National Burden of Neurological Disorders, 1990\u20132016: A Systematic Analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Feigin","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref_2","first-page":"1","article-title":"Lysosomal Storage Diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ejhg.2011.134","article-title":"Pan-Ethnic Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy: Clinical Laboratory Analysis of >72 400 Specimens","volume":"20","author":"Sugarman","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"dmm029462","DOI":"10.1242\/dmm.029462","article-title":"Generating Mouse Models for Biomedical Research: Technological Advances","volume":"12","author":"Gurumurthy","year":"2019","journal-title":"Dis. Model. Mech."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41583-020-00382-z","article-title":"Viral Tools for Neuroscience","volume":"21","author":"Nectow","year":"2020","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41573-019-0012-9","article-title":"Adeno-Associated Virus Vector as a Platform for Gene Therapy Delivery","volume":"18","author":"Wang","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnana.2019.00093","article-title":"Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation","volume":"13","author":"Haery","year":"2019","journal-title":"Front. Neuroanat."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-virology-092818-015530","article-title":"Recombinant Adeno-Associated Virus Gene Therapy in Light of Luxturna (and Zolgensma and Glybera): Where Are We, and How Did We Get Here?","volume":"6","author":"Keeler","year":"2019","journal-title":"Annu. Rev. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1089\/hum.2016.087","article-title":"Adeno-Associated Virus-Based Gene Therapy for CNS Diseases","volume":"27","author":"Hocquemiller","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuron.2019.02.017","article-title":"Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality","volume":"101","author":"Hudry","year":"2019","journal-title":"Neuron"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/ejn.14603","article-title":"Optogenetic and Chemogenetic Insights into the Neurocircuitry of Depression-like Behaviour: A Systematic Review","volume":"53","author":"Biselli","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.omtm.2019.11.012","article-title":"Adeno-Associated Viral Vectors in Neuroscience Research","volume":"17","author":"Haggerty","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev-neuro-080317-062048","article-title":"Viral Strategies for Targeting the Central and Peripheral Nervous Systems","volume":"41","author":"Bedbrook","year":"2018","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_14","first-page":"1","article-title":"A Comparison of AAV-Vector Production Methods for Gene Therapy and Preclinical Assessment","volume":"10","author":"Davidsson","year":"2020","journal-title":"Sci. Reports"},{"key":"ref_15","first-page":"49","article-title":"Viral Expression Cassette Elements to Enhance Transgene Target Specificity and Expression in Gene Therapy","volume":"19","author":"Powell","year":"2015","journal-title":"Discov. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"104951","DOI":"10.1016\/j.nbd.2020.104951","article-title":"Use of Adeno-Associated Virus-Mediated Delivery of Mutant Huntingtin to Study the Spreading Capacity of the Protein in Mice and Non-Human Primates","volume":"141","author":"Maxan","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"347ra94","DOI":"10.1126\/scitranslmed.aaf5660","article-title":"An MiRNA-Mediated Therapy for SCA6 Blocks IRES-Driven Translation of the CACNA1A Second Cistron","volume":"8","author":"Miyazaki","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1007\/s13311-019-00823-3","article-title":"Repeat Expansion Disorders: Mechanisms and Therapeutics","volume":"16","author":"Ellerby","year":"2019","journal-title":"Neurotherapeutics"},{"key":"ref_19","first-page":"859","article-title":"Viral Delivery of C9orf72 Hexanucleotide Repeat Expansions in Mice Leads to Repeat-Length-Dependent Neuropathology and Behavioural Deficits","volume":"10","author":"Chandran","year":"2017","journal-title":"Dis. Model. Mech."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13024-019-0310-z","article-title":"Aberrant Deposition of Stress Granule-Resident Proteins Linked to C9orf72-Associated TDP-43 Proteinopathy","volume":"14","author":"Chew","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108718","DOI":"10.1016\/j.celrep.2021.108718","article-title":"G\u03b1o Is a Major Determinant of CAMP Signaling in the Pathophysiology of Movement Disorders","volume":"34","author":"Muntean","year":"2021","journal-title":"Cell Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1073\/pnas.1920008117","article-title":"Loss-of-Function BK Channel Mutation Causes Impaired Mitochondria and Progressive Cerebellar Ataxia","volume":"117","author":"Du","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/brain\/awr348","article-title":"Non-Human Primate Model of Amyotrophic Lateral Sclerosis with Cytoplasmic Mislocalization of TDP-43","volume":"135","author":"Uchida","year":"2012","journal-title":"Brain"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1326-2-11","article-title":"Novel Rat Alzheimer\u2019s Disease Models Based on AAV-Mediated Gene Transfer to Selectively Increase Hippocampal A\u03b2 Levels","volume":"2","author":"Lawlor","year":"2007","journal-title":"Mol. Neurodegener."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1528-1167.2010.02947.x","article-title":"Adenosine Kinase as a Target for Therapeutic Antisense Strategies in Epilepsy","volume":"52","author":"Theofilas","year":"2011","journal-title":"Epilepsia"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3171\/2013.10.JNS13918","article-title":"Overexpression of Adenosine Kinase in Cortical Astrocytes and Focal Neocortical Epilepsy in Mice: Laboratory Investigation","volume":"120","author":"Shen","year":"2014","journal-title":"J. Neurosurg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s12640-020-00256-3","article-title":"Peripheral ProBDNF Delivered by an AAV Vector to the Muscle Triggers Depression-Like Behaviours in Mice","volume":"38","author":"Lin","year":"2020","journal-title":"Neurotox. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e12765","DOI":"10.1111\/gbb.12765","article-title":"The Role of SIRT1 in the Basolateral Amygdala in Depression-like Behaviors in Mice","volume":"20","author":"Guo","year":"2021","journal-title":"Genes Brain Behav."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/mt.2013.285","article-title":"Recombinant AAV as a Platform for Translating the Therapeutic Potential of RNA Interference","volume":"22","author":"Borel","year":"2014","journal-title":"Mol. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymeth.2016.04.003","article-title":"Guidelines for the Optimal Design of MiRNA-Based ShRNAs","volume":"103","author":"Gu","year":"2016","journal-title":"Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.24332","article-title":"A Large Animal Model of Spinal Muscular Atrophy and Correction Of","volume":"77","author":"Duque","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"104513","DOI":"10.1016\/j.nbd.2019.104513","article-title":"Viral Delivery of a MicroRNA to Gba to the Mouse Central Nervous System Models Neuronopathic Gaucher Disease","volume":"130","author":"Jackson","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-9139-6_1","article-title":"Design of AAV Vectors for Delivery of RNAi","volume":"1950","author":"Borel","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e300","DOI":"10.1038\/emm.2016.163","article-title":"In Vitro Generation of Mature Midbrain-Type Dopamine Neurons by Adjusting Exogenous Nurr1 and Foxa2 Expressions to Their Physiologic Patterns","volume":"49","author":"Kim","year":"2017","journal-title":"Exp. Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41434-020-0169-1","article-title":"Optimization of Adeno-Associated Viral Vector-Mediated Transduction of the Corticospinal Tract: Comparison of Four Promoters","volume":"28","author":"Nieuwenhuis","year":"2020","journal-title":"Gene Ther."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1089\/hum.2010.245","article-title":"Optimizing Promoters for Recombinant Adeno-Associated Virus-Mediated Gene Expression in the Peripheral and Central Nervous System Using Self-Complementary Vectors","volume":"22","author":"Gray","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.neuroscience.2020.04.004","article-title":"Global Knockdown of Retinoid-Related Orphan Receptor \u03b1 in Mature Purkinje Cells Reveals Aberrant Cerebellar Phenotypes of Spinocerebellar Ataxia","volume":"462","author":"Yasui","year":"2021","journal-title":"Neuroscience"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1758-907X-2-8","article-title":"The Dose Can Make the Poison: Lessons Learned from Adverse in Vivo Toxicities Caused by RNAi Overexpression","volume":"2","author":"Grimm","year":"2011","journal-title":"Silence"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1471-4159.2006.04310.x","article-title":"Dopaminergic Neuron Loss and Up-Regulation of Chaperone Protein MRNA Induced by Targeted over-Expression of Alpha-Synuclein in Mouse Substantia Nigra","volume":"100","author":"Klucken","year":"2007","journal-title":"J. Neurochem."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Hammond, S.L., Leek, A.N., Richman, E.H., and Tjalkens, R.B. (2017). Cellular Selectivity of AAV Serotypes for Gene Delivery in Neurons and Astrocytes by Neonatal Intracerebroventricular Injection. PLoS One, 12.","DOI":"10.1371\/journal.pone.0188830"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1016\/j.ymthe.2021.07.010","article-title":"A Comprehensive Study of a 29-Capsid AAV Library in a Non-Human Primate Central Nervous System","volume":"29","author":"Kondratov","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.omtm.2018.07.006","article-title":"Efficient Gene Transfer to the Central Nervous System by Single-Stranded Anc80L65","volume":"10","author":"Hudry","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cresto, N., Gardier, C., Gaillard, M.C., Gubinelli, F., Roost, P., Molina, D., Josephine, C., Dufour, N., Auregan, G., and Guillermier, M. (2021). The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T \u03b1-Synuclein Toxicity in Dopaminergic Neurons In Vivo. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136760"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1096\/fj.201701529RR","article-title":"Cre-Dependent AAV Vectors for Highly Targeted Expression of Disease-Related Proteins and Neurodegeneration in the Substantia Nigra","volume":"32","author":"Grames","year":"2018","journal-title":"FASEB J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic Silencing of Mutant Huntingtin with SiRNA Attenuates Striatal and Cortical Neuropathology and Behavioral Deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1111\/j.1460-9568.2012.08193.x","article-title":"Characterization of a Rat Model of Huntington\u2019s Disease Based on Targeted Expression of Mutant Huntingtin in the Forebrain Using Adeno-Associated Viral Vectors","volume":"36","author":"Gabery","year":"2012","journal-title":"Eur. J. Neurosci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fncel.2018.00157","article-title":"Adeno-Associated Viral Vector Serotype DJ-Mediated Overexpression of N171-82Q-Mutant Huntingtin in the Striatum of Juvenile Mice Is a New Model for Huntington\u2019s Disease","volume":"12","author":"Jang","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3340\/jkns.2019.0182","article-title":"An Optimization of AAV-82Q-Delivered Rat Model of Huntington\u2019s Disease","volume":"63","author":"So","year":"2020","journal-title":"J. Korean Neurosurg. Soc."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Audrain, M., Fol, R., Dutar, P., Potier, B., Billard, J.M., Flament, J., Alves, S., Burlot, M.A., Dufayet-Chaffaud, G., and Bemelmans, A.P. (2016). Alzheimer\u2019s Disease-like APP Processing in Wild-Type Mice Identifies Synaptic Defects as Initial Steps of Disease Progression. Mol. Neurodegener., 11.","DOI":"10.1186\/s13024-016-0070-y"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Jaworski, T., Dewachter, I., Lechat, B., Croes, S., Termont, A., Demedts, D., Borghgraef, P., Devijver, H., Filipkowski, R.K., and Kaczmarek, L. (2009). AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice. PLoS One, 4.","DOI":"10.1371\/journal.pone.0007280"},{"key":"ref_51","first-page":"116","article-title":"Better Targeting, Better Efficiency for Wide-Scale Neuronal Transduction with the Synapsin Promoter and AAV-PHP.B","volume":"9","author":"Jackson","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Perez, B.A., Shutterly, A., Chan, Y.K., Byrne, B.J., and Corti, M. (2020). Management of Neuroinflammatory Responses to AAV-Mediated Gene Therapies for Neurodegenerative Diseases. Brain Sci., 10.","DOI":"10.3390\/brainsci10020119"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1089\/humc.2017.010","article-title":"Persistent Expression of Dopamine-Synthesizing Enzymes 15 Years After Gene Transfer in a Primate Model of Parkinson\u2019s Disease","volume":"28","author":"Sehara","year":"2017","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/alz.12318","article-title":"A Novel Tau-based Rhesus Monkey Model of Alzheimer\u2019s Pathogenesis","volume":"17","author":"Beckman","year":"2021","journal-title":"Alzheimers Dement."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/emmm.201302475","article-title":"Caudo-Rostral Brain Spreading of \u03b1-Synuclein through Vagal Connections","volume":"5","author":"Ulusoy","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"15036","DOI":"10.1038\/mtm.2015.36","article-title":"AAV9 Supports Wide-Scale Transduction of the CNS and TDP-43 Disease Modeling in Adult Rats","volume":"2","author":"Jackson","year":"2015","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cmet.2011.02.013","article-title":"Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits","volume":"13","author":"Hult","year":"2011","journal-title":"Cell Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2015.11.019","article-title":"Recombinant Adeno Associated Viral (AAV) Vector Type 9 Delivery of Ex1-Q138-Mutant Huntingtin in the Rat Striatum as a Short-Time Model for in Vivo Studies in Drug Discovery","volume":"86","author":"Ceccarelli","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV Vector\u2013Mediated RNAi of Mutant Huntingtin Expression Is Neuroprotective in a Novel Genetic Rat Model of Huntington\u2019s Disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol. Ther."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jnc.14670","article-title":"Adeno-Associated Virus-Mediated over-Expression of CREB-Regulated Transcription Coactivator 1 in the Hippocampal Dentate Gyrus Ameliorates Lipopolysaccharide-Induced Depression-like Behaviour in Mice","volume":"149","author":"Ni","year":"2019","journal-title":"J. Neurochem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.biopsych.2014.03.009","article-title":"Calcineurin Down-Regulation in the Amygdala Is Sufficient to Induce Anxiety-like and Depression-like Behaviors in C57BL\/6J Male Mice","volume":"75","author":"Mineur","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Choi, M., Wang, S.E., Ko, S.Y., Kang, H.J., Chae, S.Y., Lee, S.H., Kim, Y.S., Duman, R.S., and Son, H. (2014). Overexpression of Human GATA-1 and GATA-2 Interferes with Spine Formation and Produces Depressive Behavior in Rats. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0109253"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12974-018-1377-0","article-title":"Hippocampal CA1 \u0392caMKII Mediates Neuroinflammatory Responses via COX-2\/PGE2 Signaling Pathways in Depression","volume":"15","author":"Song","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/nm.2886","article-title":"Decreased Expression of Synapse-Related Genes and Loss of Synapses in Major Depressive Disorder","volume":"18","author":"Kang","year":"2012","journal-title":"Nat. Med."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association (2021). 2021 Alzheimer\u2019s Disease Facts and Figures. Alzheimers Dement., 17, 327\u2013406.","DOI":"10.1002\/alz.12328"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1255555","DOI":"10.1126\/science.1255555","article-title":"Alzheimer\u2019s and Parkinson\u2019s Diseases: The Prion Concept in Relation to Assembled A\u03b2, Tau, and \u03b1-Synuclein","volume":"349","author":"Goedert","year":"2015","journal-title":"Science"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/NEN.0b013e318232a379","article-title":"Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years","volume":"70","author":"Braak","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_68","unstructured":"Conn, P.M. (2006). Handbook of Models for Human Aging, Elsevier Academic Press."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.neuroscience.2015.12.011","article-title":"Obesity, Diabetes, and Leptin Resistance Promote Tau Pathology in a Mouse Model of Disease","volume":"315","author":"Platt","year":"2016","journal-title":"Neuroscience"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.bbadis.2013.04.017","article-title":"Transgenic Models of Alzheimer\u2019s Disease: Better Utilization of Existing Models through Viral Transgenesis","volume":"1832","author":"Platt","year":"2013","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41583-018-0054-8","article-title":"Rodent Models for Alzheimer Disease","volume":"19","author":"Bodea","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1111\/bph.14637","article-title":"Adeno-associated Virus-based Alzheimer\u2019s Disease Mouse Models and Potential New Therapeutic Avenues","volume":"176","author":"Ittner","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000445751","article-title":"The Incidence of Parkinson\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"46","author":"Hirsch","year":"2016","journal-title":"Neuroepidemiology"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"R48","DOI":"10.1093\/hmg\/ddp012","article-title":"Parkinson\u2019s Disease: From Monogenic Forms to Genetic Susceptibility Factors","volume":"18","author":"Lesage","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-015-0046-9","article-title":"No Apparent Transmission of Transgenic \u03b1\u2013Synuclein into Nigrostriatal Dopaminergic Neurons in Multiple Mouse Models","volume":"4","author":"Sastry","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/jnr.21310","article-title":"Accumulation of Phosphorylated \u03b1-Synuclein in Dopaminergic Neurons of Transgenic Mice That Express Human \u03b1-Synuclein","volume":"85","author":"Wakamatsu","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jnc.13627","article-title":"How Can RAAV-\u03b1-Synuclein and the Fibril \u03b1-Synuclein Models Advance Our Understanding of Parkinson\u2019s Disease?","volume":"139","author":"Kirik","year":"2016","journal-title":"J. Neurochem."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Albert, K., Voutilainen, M.H., Domanskyi, A., and Airavaara, M. (2017). AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease Models. Genes, 8.","DOI":"10.3390\/genes8020063"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00441-017-2730-9","article-title":"In Vivo Models of Alpha-Synuclein Transmission and Propagation","volume":"373","author":"Recasens","year":"2017","journal-title":"Cell Tissue Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.14336\/AD.2021.0517","article-title":"Adeno-Associated Virus Expression of \u03b1-Synuclein as a Tool to Model Parkinson\u2019s Disease: Current Understanding and Knowledge Gaps","volume":"12","author":"Huntington","year":"2021","journal-title":"Aging Dis."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","article-title":"Amyotrophic Lateral Sclerosis","volume":"3","author":"Hardiman","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1292-e79","DOI":"10.1111\/ene.12474","article-title":"Population-Based Epidemiology of Amyotrophic Lateral Sclerosis (ALS) in an Ageing Europe \u2013 the French Register of ALS in Limousin (FRALim Register)","volume":"21","author":"Marin","year":"2014","journal-title":"Eur. J. Neurol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","article-title":"ALS Genes in the Genomic Era and Their Implications for FTD","volume":"34","author":"Nguyen","year":"2018","journal-title":"Trends Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 Hexanucleotide Repeat Expansion in Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: A Cross-Sectional Study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","article-title":"Huntington Disease","volume":"1","author":"Bates","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/jnnp-2012-304636","article-title":"Prevalence of Adult Huntington\u2019s Disease in the UK Based on Diagnoses Recorded in General Practice Records","volume":"84","author":"Evans","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington\u2019s Disease: A Clinical Review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/WNO0b013e3181b416de","article-title":"The Spinocerebellar Ataxias","volume":"29","author":"Paulson","year":"2009","journal-title":"J. Neuroophthalmol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000358801","article-title":"The Global Epidemiology of Hereditary Ataxia and Spastic Paraplegia: A Systematic Review of Prevalence Studies","volume":"42","author":"Ruano","year":"2014","journal-title":"Neuroepidemiology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3389\/fnins.2020.00571","article-title":"Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion","volume":"14","author":"Hache","year":"2020","journal-title":"Front. Neurosci."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/002215540405200302","article-title":"Immunohistochemical Characterization of the Orphan Nuclear Receptor ROR\u03b1 in the Mouse Nervous System","volume":"52","author":"Ino","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.mcn.2006.11.006","article-title":"Properties of Human Cav2.1 Channel with a Spinocerebellar Ataxia Type 6 Mutation Expressed in Purkinje Cells","volume":"34","author":"Saegusa","year":"2007","journal-title":"Mol. Cell. Neurosci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cell.2013.05.059","article-title":"A Second Cistron in the CACNA1A Gene Encodes a Transcription Factor That Mediates Cerebellar Development and SCA6","volume":"154","author":"Du","year":"2013","journal-title":"Cell"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Stirnemann, J.\u00d4., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., and Brassier, A. (2017). A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020441"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1242\/dmm.008185","article-title":"Animal Models for Gaucher Disease Research","volume":"4","author":"Vitner","year":"2011","journal-title":"Dis. Model. Mech."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/mt.2015.16","article-title":"Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice","volume":"23","author":"Dahl","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"18024","DOI":"10.1038\/nrdp.2018.24","article-title":"Epilepsy","volume":"4","author":"Devinsky","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1474-4422(19)30269-8","article-title":"Epilepsy Genetics: Clinical Impacts and Biological Insights","volume":"19","author":"Ellis","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2016.11.030","article-title":"Epilepsy-Associated Genes","volume":"44","author":"Wang","year":"2017","journal-title":"Seizure"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ajhg.2013.07.014","article-title":"De Novo Mutations in GNAO1, Encoding a G\u03b1o Subunit of Heterotrimeric G Proteins, Cause Epileptic Encephalopathy","volume":"93","author":"Nakamura","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nbd.2018.05.005","article-title":"A Mechanistic Review on GNAO1-Associated Movement Disorder","volume":"116","author":"Feng","year":"2018","journal-title":"Neurobiol. Dis."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.neuint.2013.01.028","article-title":"Glial Adenosine Kinase \u2013 a Neuropathological Marker of the Epileptic Brain","volume":"63","author":"Aronica","year":"2013","journal-title":"Neurochem. Int."},{"key":"ref_103","first-page":"1211","article-title":"Global, Regional, and National Incidence, Prevalence, and Years Lived with Disability for 328 Diseases and Injuries for 195 Countries, 1990-2016: A Systematic Analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Glob. Health Metr."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psc.2011.11.005","article-title":"The Costs of Depression","volume":"35","author":"Kessler","year":"2012","journal-title":"Psychiatr. Clin. N. Am."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s11033-019-05129-3","article-title":"The Cellular and Molecular Basis of Major Depressive Disorder: Towards a Unified Model for Understanding Clinical Depression","volume":"47","author":"Pitsillou","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41380-019-0585-z","article-title":"Prospective Biomarkers of Major Depressive Disorder: A Systematic Review and Meta-Analysis","volume":"25","author":"Kennis","year":"2020","journal-title":"Mol. Psychiatry"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.biopsych.2005.09.018","article-title":"The Mesolimbic Dopamine Reward Circuit in Depression","volume":"59","author":"Nestler","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neubiorev.2005.04.016","article-title":"The Mesolimbic Dopamine System: The Final Common Pathway for the Reinforcing Effect of Drugs of Abuse?","volume":"30","author":"Pierce","year":"2006","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/sj.mp.4000812","article-title":"The Amygdala: Vigilance and Emotion","volume":"6","author":"Davis","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/nature14659","article-title":"Sparse Whole-Genome Sequencing Identifies Two Loci for Major Depressive Disorder","volume":"523","author":"Cai","year":"2015","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.neuroscience.2013.01.024","article-title":"Social Defeat Induces Changes in Histone Acetylation and Expression of Histone Modifying Enzymes in the Ventral Hippocampus, Prefrontal Cortex, and Dorsal Raphe Nucleus","volume":"264","author":"Kenworthy","year":"2014","journal-title":"Neuroscience"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.biopsych.2018.08.021","article-title":"The Hippocampus in Depression: More Than the Sum of Its Parts? Advanced Hippocampal Substructure Segmentation in Depression","volume":"85","author":"Roddy","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A Meta-Analysis of Cytokines in Major Depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.euroneuro.2011.09.001","article-title":"Neuropathological Abnormalities of Astrocytes, GABAergic Neurons, and Pyramidal Neurons in the Dorsolateral Prefrontal Cortices of Patients with Major Depressive Disorder","volume":"22","author":"Oh","year":"2012","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-2094-11-90","article-title":"CaMKII and MEK1\/2 Inhibition Time-Dependently Modify Inflammatory Signaling in Rat Cerebral Arteries during Organ Culture","volume":"11","author":"Waldsee","year":"2014","journal-title":"J. Neuroinflammation"},{"key":"ref_116","first-page":"611","article-title":"Adeno-Associated Virus (AAV) Dual Vector Strategies for Gene Therapy Encoding Large Transgenes","volume":"90","author":"McClements","year":"2017","journal-title":"Yale J. Biol. Med."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s12985-021-01555-7","article-title":"Optimization of AAV Vectors to Target Persistent Viral Reservoirs","volume":"18","author":"Jerome","year":"2021","journal-title":"Virol. J."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2004018","DOI":"10.1002\/advs.202004018","article-title":"Synthetic Biology: Emerging Concepts to Design and Advance Adeno-Associated Viral Vectors for Gene Therapy","volume":"8","author":"Wagner","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.omtm.2021.07.001","article-title":"High Throughput Screening of Novel AAV Capsids Identifies Variants for Transduction of Adult NSCs within the Subventricular Zone","volume":"23","author":"Kremer","year":"2021","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/hum.2019.264","article-title":"High-Throughput in Vitro, Ex Vivo, and in Vivo Screen of Adeno-Associated Virus Vectors Based on Physical and Functional Transduction","volume":"31","author":"Westhaus","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"fcab105","DOI":"10.1093\/braincomms\/fcab105","article-title":"Use of High-Content Imaging to Quantify Transduction of AAV-PHP Viruses in the Brain Following Systemic Delivery","volume":"3","author":"Smith","year":"2021","journal-title":"Brain Commun."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"E5689","DOI":"10.1073\/pnas.1506129112","article-title":"Consequences of Zygote Injection and Germline Transfer of Mutant Human Mitochondrial DNA in Mice","volume":"112","author":"Yu","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:11:00Z","timestamp":1760137860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/5\/1140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,15]]},"references-count":122,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["biomedicines10051140"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10051140","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,15]]}}}